Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements.
Anna Szumera-CiećkiewiczGrzegorz RymkiewiczKamil SokółEwa Paszkiewicz-KozikAnita BorysiukJan PoleszczukKatarzyna BachnioZbigniew BystydzienskiRenata WoronieckaBeata GrygalewiczMartyna KotarskaMonika StańczakDaria OwczarekBeata PytlakMonika Prochorec-SobieszekJan WalewskiPublished in: International journal of laboratory hematology (2020)
Immunohistochemistry staining is a comparable method to FCM assessment in the evaluation of CD10 expression and diagnosis of FL. Fine-needle aspiration biopsy/FCM (FNAB/FCM) could be a useful tool for verifying FL diagnosis and CD10 detection. Despite its heterogeneity, FL has a characteristic immunophenotype. BCL2R and BCL6R FL cases differ mainly in levels of BCL2 and CD10 with CD43 co-expression; BCL2(+)higher by FCM correlates with BCL2R. Moreover, FNAB plays an important role in material provision for supportive karyotyping and BCL2R, BCL6R assessed by FISH.